QRVO
6
2
MCO
73
3
FMC
31
5
URBN
38
-4
UHS
54
3
VTR
49
-3
PNW
66
3
IVZ
46
3
EXC
54
-2
F
43
-8
IR
63
3
ZTS
47
2
CAH
47
3
VRTX
46
2
HAS
30
2
CINF
47
2
IFF
53
2
DAL
80
-4
A
36
2
ILMN
32
-3
QRVO
6
2
MCO
73
3
FMC
31
5
URBN
38
-4
UHS
54
3
VTR
49
-3
PNW
66
3
IVZ
46
3
EXC
54
-2
F
43
-8
IR
63
3
ZTS
47
2
CAH
47
3
VRTX
46
2
HAS
30
2
CINF
47
2
IFF
53
2
DAL
80
-4
A
36
2
ILMN
32
-3
Financhill
Back

MoonLake Immunotherapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
62

MLTX
MoonLake Immunotherapeutics

Last Price:
52.02
Seasonality Move:
36.4%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

MoonLake Immunotherapeutics Price Quote

$52.02
+2.20 (+4.42%)
(Updated: November 21, 2024 at 5:55 PM ET)

MoonLake Immunotherapeutics Key Stats

Buy
62
MoonLake Immunotherapeutics (MLTX) is a Buy
Day range:
$48.97 - $50.98
52-week range:
$37.55 - $64.98
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
6.27%
Volume:
191K
Avg. volume:
228.3K
1-year change:
16.76%
Market cap:
$3.1B
Revenue:
$0
EPS:
$-1.27

How Much Does MoonLake Immunotherapeutics Make?

Data Unavailable

Is MoonLake Immunotherapeutics Growing As A Company?

Data Unavailable

MoonLake Immunotherapeutics Stock Price Performance

What Is MoonLake Immunotherapeutics 52-Week High & Low?

MoonLake Immunotherapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy MoonLake Immunotherapeutics?

Is MoonLake Immunotherapeutics Cash Flow Positive?

  • What Is MLTX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$80.5M
  • What Is MoonLake Immunotherapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $79.6M
  • What Is MoonLake Immunotherapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $58.6M

MoonLake Immunotherapeutics Return On Invested Capital

Data Unavailable

MoonLake Immunotherapeutics Earnings Date & Stock Price

MoonLake Immunotherapeutics Competitors

MoonLake Immunotherapeutics Dividend Yield

MoonLake Immunotherapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -23.33%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 73.92
Upside from Last Price: 48.38%

Major Shareholders

  • How many MLTX shares are owned by institutional investors?
    100.4M MLTX shares are owned by institutional investors
  • How many MLTX shares are owned by insiders?
    3.7M MLTX shares are owned by insiders